11 results
Eating disorders: Initial assessment in primary care #Management #PrimaryCare #Endo #EatingDisorders #Anorexia #Bulimia #Nervosa #BMJ
disorders: Initial assessment ... care #Management #PrimaryCare ... #Endo #EatingDisorders ... Bulimia #Nervosa #BMJ
Suspected sepsis: Summary of NICE guidlelines #Diagnosis #Management #EM #IM #PrimaryCare #Sepsis #NICE #Monitoring #BMJ
Diagnosis #Management #EM ... #IM #PrimaryCare ... NICE #Monitoring #BMJ
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
Dizziness #Diagnosis #PrimaryCare ... #EM #IM #Differential ... Lightheadedness #Table #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Nonvertebral Fracture #EBM ... #PrimaryCare #Endo ... #IM #Romosozumab ... #Alendronate #NEJM
Management of type 2 diabetes in adults: summary of updated NICE guidance #Management #IM #PrimaryCare #Endo
guidance #Management #IM ... #PrimaryCare #Endo ... #DM2 #BMJ
Diagnostic flow chart for rash in pregnancy.8 CMV: cytomegalovirus. EBV: Epstein Barr virus. Source: adapted from
EBV: Epstein Barr ... 2011 #Diagnosis #PrimaryCare ... #Derm #EM #Rash ... PregnancyRash #BMJ
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
and Secondary End ... Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
and Secondary End ... Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Insulin-Mediated Lipohypertrophy - Two painless, rubbery, hyperpigmented masses were noted near the umbilical area. The patient
#Clinical #Derm ... #Endo #PrimaryCare ... Lipohypertrophy #Insulin #NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
of the primary end ... warfarin (Panel A) #EBM ... #Cardiology #IM ... AtrialFibrillation #NEJM